Mevalonate kinase

From Wikipedia, the free encyclopedia
Mevalonate Kinase

Crystallographic structure of mevalonate kinase from Staphylococcus aureus.[1]
Identifiers
EC number 2.7.1.36
CAS number 9026-52-2
Databases
IntEnz IntEnz view
BRENDA BRENDA entry
ExPASy NiceZyme view
KEGG KEGG entry
MetaCyc metabolic pathway
PRIAM profile
PDB structures RCSB PDB PDBe PDBsum
Gene Ontology AmiGO / EGO
Mevalonate kinase

PDB rendering based on 2r3v.
Available structures
PDB Ortholog search: PDBe, RCSB
Identifiers
SymbolsMVK; LRBP; MK; MVLK; POROK3
External IDsOMIM: 251170 MGI: 107624 HomoloGene: 372 GeneCards: MVK Gene
EC number2.7.1.36
Orthologs
SpeciesHumanMouse
Entrez459817855
EnsemblENSG00000110921ENSMUSG00000041939
UniProtQ03426Q9R008
RefSeq (mRNA)NM_000431NM_023556
RefSeq (protein)NP_000422NP_076045
Location (UCSC)Chr 12:
110.01 – 110.04 Mb		Chr 5:
114.44 – 114.46 Mb
PubMed search
This box:

Mevalonate kinase is an enzyme that in humans is encoded by the MVK gene.[2][3] Mevalonate kinases are found in a wide variety of organisms from bacteria to mammals. This enzyme catalyzes the following reaction:

ATP + (R)-mevalonate \rightleftharpoons ADP + (R)-5-phosphomevalonate
.

Function

Mevalonate is a key intermediate, and mevalonate kinase a key early enzyme, in isoprenoid and sterol synthesis.[2]

Mevalonate pathway

Clinical significance

Defects can be associated with hyperimmunoglobulinemia D with recurrent fever.[4]

Mevalonate kinase deficiency caused by mutation of this gene results in mevalonic aciduria, a disease characterized psychomotor retardation, failure to thrive, hepatosplenomegaly, anemia and recurrent febrile crises. Defects in this gene also cause hyperimmunoglobulinaemia D and periodic fever syndrome, a disorder characterized by recurrent episodes of fever associated with lymphadenopathy, arthralgia, gastrointestinal dismay and skin rash.[2]

See also

References

  1. ↑ PDB 2X7I; Oke M, Carter LG, Johnson KA, Liu H, McMahon SA, Yan X, Kerou M, Weikart ND, Kadi N, Sheikh MA, Schmelz S, Dorward M, Zawadzki M, Cozens C, Falconer H, Powers H, Overton IM, van Niekerk CA, Peng X, Patel P, Garrett RA, Prangishvili D, Botting CH, Coote PJ, Dryden DT, Barton GJ, Schwarz-Linek U, Challis GL, Taylor GL, White MF, Naismith JH (June 2010). "The Scottish Structural Proteomics Facility: targets, methods and outputs". J. Struct. Funct. Genomics 11 (2): 167–80. doi:10.1007/s10969-010-9090-y. PMC 2883930. PMID 20419351. 
  2. ↑ 2.0 2.1 2.2 "Entrez Gene: mevalonate kinase". 
  3. ↑ Schafer BL, Bishop RW, Kratunis VJ, Kalinowski SS, Mosley ST, Gibson KM, Tanaka RD (July 1992). "Molecular cloning of human mevalonate kinase and identification of a missense mutation in the genetic disease mevalonic aciduria". J. Biol. Chem. 267 (19): 13229–38. PMID 1377680. 
  4. ↑ Online 'Mendelian Inheritance in Man' (OMIM) 260920


Further reading

  • Ma J, Dempsey AA, Stamatiou D, et al. (2007). "Identifying leukocyte gene expression patterns associated with plasma lipid levels in human subjects.". Atherosclerosis 191 (1): 63–72. doi:10.1016/j.atherosclerosis.2006.05.032. PMID 16806233. 
  • Willer CJ, Sanna S, Jackson AU, et al. (2008). "Newly identified loci that influence lipid concentrations and risk of coronary artery disease.". Nat. Genet. 40 (2): 161–9. doi:10.1038/ng.76. PMID 18193043. 
  • Naruto T, Nakagishi Y, Mori M, et al. (2009). "Hyper-IgD syndrome with novel mutation in a Japanese girl.". Mod Rheumatol 19 (1): 96–9. doi:10.1007/s10165-008-0130-4. PMID 18941711. 
  • Krisans SK (1992). "The role of peroxisomes in cholesterol metabolism.". Am. J. Respir. Cell Mol. Biol. 7 (4): 358–64. PMID 1356376. 
  • Houten SM, Wanders RJ, Waterham HR (2000). "Biochemical and genetic aspects of mevalonate kinase and its deficiency.". Biochim. Biophys. Acta 1529 (1-3): 19–32. PMID 11111075. 
  • Fu Z, Voynova NE, Herdendorf TJ, et al. (2008). "Biochemical and structural basis for feedback inhibition of mevalonate kinase and isoprenoid metabolism.". Biochemistry 47 (12): 3715–24. doi:10.1021/bi7024386. PMID 18302342. 
  • Kathiresan S, Willer CJ, Peloso GM, et al. (2009). "Common variants at 30 loci contribute to polygenic dyslipidemia.". Nat. Genet. 41 (1): 56–65. doi:10.1038/ng.291. PMC 2881676. PMID 19060906. 
  • Hager EJ, Gibson KM (2007). "Mevalonate kinase deficiency and autoinflammation.". N. Engl. J. Med. 357 (18): 1871–2. doi:10.1056/NEJMc072799. PMID 17978300. 
  • Marques-Vidal P, Bochud M, Paccaud F, et al. (2010). "No interaction between alcohol consumption and HDL-related genes on HDL cholesterol levels.". Atherosclerosis 211 (2): 551–7. doi:10.1016/j.atherosclerosis.2010.04.001. PMID 20430392. 
  • Lu Y, Dollé ME, Imholz S, et al. (2008). "Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations.". J. Lipid Res. 49 (12): 2582–9. doi:10.1194/jlr.M800232-JLR200. PMID 18660489. 
  • Samkari A, Borzutzky A, Fermo E, et al. (2010). "A novel missense mutation in MVK associated with MK deficiency and dyserythropoietic anemia.". Pediatrics 125 (4): e964–8. doi:10.1542/peds.2009-1774. PMID 20194276. 
  • Nakayama K, Bayasgalan T, Yamanaka K, et al. (2009). "Large scale replication analysis of loci associated with lipid concentrations in a Japanese population.". J. Med. Genet. 46 (6): 370–4. doi:10.1136/jmg.2008.064063. PMID 19487539. 
  • Koné-Paut I, Sanchez E, Le Quellec A, et al. (2007). "Autoinflammatory gene mutations in Behçet's disease.". Ann. Rheum. Dis. 66 (6): 832–4. doi:10.1136/ard.2006.068841. PMID 17213252. 
  • Weissglas-Volkov D, Aguilar-Salinas CA, Sinsheimer JS, et al. (2010). "Investigation of variants identified in caucasian genome-wide association studies for plasma high-density lipoprotein cholesterol and triglycerides levels in Mexican dyslipidemic study samples.". Circ Cardiovasc Genet 3 (1): 31–8. doi:10.1161/CIRCGENETICS.109.908004. PMID 20160193. 
  • Simon A, van der Meer JW, Vesely R, et al. (2006). "Approach to genetic analysis in the diagnosis of hereditary autoinflammatory syndromes.". Rheumatology (Oxford) 45 (3): 269–73. doi:10.1093/rheumatology/kei138. PMID 16234278. 
  • Gattorno M, Sormani MP, D'Osualdo A, et al. (2008). "A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children.". Arthritis Rheum. 58 (6): 1823–32. doi:10.1002/art.23474. PMID 18512793. 
  • Fogarty MP, Xiao R, Prokunina-Olsson L, et al. (2010). "Allelic expression imbalance at high-density lipoprotein cholesterol locus MMAB-MVK.". Hum. Mol. Genet. 19 (10): 1921–9. doi:10.1093/hmg/ddq067. PMID 20159775. 
  • Nair AK, Young MA, Menon KM (2008). "Regulation of luteinizing hormone receptor mRNA expression by mevalonate kinase--role of the catalytic center in mRNA recognition.". FEBS J. 275 (13): 3397–407. doi:10.1111/j.1742-4658.2008.06490.x. PMID 18494797. 
  • Deo RC, Reich D, Tandon A, et al. (2009). "Genetic differences between the determinants of lipid profile phenotypes in African and European Americans: the Jackson Heart Study.". PLoS Genet. 5 (1): e1000342. doi:10.1371/journal.pgen.1000342. PMID 19148283. 
  • Junyent M, Parnell LD, Lai CQ, et al. (2009). "Novel variants at KCTD10, MVK, and MMAB genes interact with dietary carbohydrates to modulate HDL-cholesterol concentrations in the Genetics of Lipid Lowering Drugs and Diet Network Study.". Am. J. Clin. Nutr. 90 (3): 686–94. doi:10.3945/ajcn.2009.27738. PMID 19605566. 

External links

Transferases: phosphorus-containing groups (EC 2.7)
2.7.1-2.7.4:
phosphotransferase/kinase
(PO4)
2.7.1: OH acceptor
2.7.2: COOH acceptor
2.7.3: N acceptor
2.7.4: PO4 acceptor
2.7.6: diphosphotransferase
(P2O7)
2.7.7: nucleotidyltransferase
(PO4-nucleoside)
Polymerase
DNA polymerase
DNA-directed DNA polymerase
I
II
III
IV
V
RNA-directed DNA polymerase
Reverse transcriptase
Telomerase
DNA nucleotidylexotransferase/Terminal deoxynucleotidyl transferase
RNA nucleotidyltransferase
Phosphorolytic
3' to 5' exoribonuclease
Uridylyltransferase
  • Glucose-1-phosphate uridylyltransferase
  • Galactose-1-phosphate uridylyltransferase
Guanylyltransferase
  • mRNA capping enzyme
Other
2.7.8: miscellaneous
Phosphatidyltransferases
Glycosyl-1-phosphotransferase
2.7.10-2.7.13: protein kinase
(PO4; protein acceptor)
2.7.10: protein-tyrosine
  • see tyrosine kinases
2.7.11: protein-serine/threonine
  • see serine/threonine-specific protein kinases
2.7.12: protein-dual-specificity
  • see serine/threonine-specific protein kinases
2.7.13: protein-histidine
  • B
  • enzm
  • 1.1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 10
    • 11
    • 13
    • 14
    • 15-18
  • 2.1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
      • 2.7.10
      • 11-12
    • 8
  • 3.1
      • 3.1.3.48
    • 2
    • 3
    • 4
      • 3.4.21
      • 22
      • 23
      • 24
    • 5
    • 6
    • 7
  • 4.1
    • 2
    • 3
    • 4
    • 5
    • 6
  • 5.1
    • 2
    • 3
    • 4
    • 99
  • 6.1-3
    • 4
    • 5-6
Metabolism: lipid metabolism – ketones/cholesterol synthesis enzymes/steroid metabolism
Mevalonate pathway
To HMG-CoA
Ketogenesis
To Mevalonic acid
To DMAPP
Geranyl-
To cholesterol
To lanosterol
7-Dehydrocholesterol path
Desmosterol path
To Bile acids
Steroidogenesis
To pregnenolone
To corticosteroids
To sex hormones
To androgens
To estrogens
Other/ungrouped

M: MET

mt, k, c/g/r/p/y/i, f/h/s/l/o/e, a/u, n, m

k, cgrp/y/i, f/h/s/l/o/e, au, n, m, epon

m (A16/C10), i (k, c/g/r/p/y/i, f/h/s/o/e, a/u, n, m)

M: END

anat/phys/devp/horm

noco (d)/cong/tumr, sysi/epon

proc, drug (A10/H1/H2/H3/H5)


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.